Post-COVID Conditions (Long COVID or ‘Long Haulers’)
| Phase of Development | Phase 2 |
| Status | Ongoing |
| Number of Subjects | Up to 80 |
| Study Drug | Ampligen® |
| Primary Endpoint | PROMIS® Fatigue Score |
| Secondary Endpoint | 6-minute walk test; Patient Reported Outcomes |
| Clinical Trials NCT # | NCT05592418 |